Insights On Clinical Technologies

1. Driving Efficiencies In eTMF With AI 8/12/2021

   The latest innovations in eTMF technology, including artificial intelligence tools, are advancing how the industry works and enabling strategic process improvements.

2. Why Is Oncology Drug Development Late To The Digital Biomarkers Game? 6/15/2021

   Despite tremendous advances in precision medicine, immunotherapy, and targeted treatments over the last several decades, oncology drug development research has lagged behind other therapeutic areas in the adoption of wearable digital biomarker technologies, such as actigraphy. This article explores the unique challenges of oncology research and the benefits that wearable technology offers within this therapeutic area.

3. Build A Better Study: Six Must-Know EDC Guidelines 12/17/2021

   You’ve just been handed a protocol and asked to build it out in your EDC system. How can you make sure that the protocol is implemented in a way that maximizes efficiency and data quality? Learn how in the available white paper.

4. Right-Size Your Technology And Unlock New Efficiencies In Medical Device And Diagnostics Trials 9/13/2022

   With the constant pressures to do more with less, it can be overwhelming for medical device and diagnostics (MDD) researchers to plan out clinical trials while supporting the vast array of technology and services. 

5. Veeva Unified Clinical Operations Survey: Annual CRO Report 3/4/2021

   New research reveals more CROs are taking action to meet the urgent need for faster clinical trials. Read the Annual CRO Report to learn what actions CROs are taking to streamline clinical operations.

6. Mobile Assessments For Parkinson’s Disease Research 3/30/2022

   In this video, see firsthand fit-for-purpose mobile assessments and applications designed to measure endpoints in Parkinson’s Disease. 

7. Expanding Flexibility Of eCOA Data Collection With Controlled Interview Mode 1/31/2022

   By allowing the collection of ePROs by trained personnel during a remote interview, discover how the interview mode constitutes an additional data entry mode when clinical trial participants cannot go to the study site for a scheduled visit.

8. The Role Of Real World Evidence To Support US FDA And TGA Registrations 9/22/2022

   Real world evidence (RWE) can contribute valuable information to new medicine registrations, in particular, for diseases that are difficult to assess in randomized clinical trials (RCTs) and for emerging technologies.

9. Ensuring Your BYOD Strategy Meets The Rigor Of Regulators 5/2/2022

   Once sponsors add eCOAs in DCTs and hybrid trials, a common question emerges: Can patients reliably complete eCOAs on their personal devices?

10. Data Governance In The Clinical Trial Ecosystem 2/24/2022

    Data governance aligns people, processes, and information technology in order to optimize the use and value of data across a business enterprise. Discover how this formal practice helps sponsors collect, integrate, and analyze data strategically to advance their drug development programs.